Search Results - "Herman, Terence"

Refine Results
  1. 1

    Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs by Aravindan, Natarajan, Somasundaram, Dinesh Babu, Herman, Terence S., Aravindan, Sheeja

    Published in Cell biology and toxicology (01-06-2021)
    “…High-risk neuroblastoma (HR-NB) is branded with hematogenous metastasis, relapses, and dismal long-term survival. Intensification of consolidation therapy with…”
    Get full text
    Journal Article
  2. 2

    Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae by Aravindan, Sheeja, Delma, Caroline R, Thirugnanasambandan, Somasundaram S, Herman, Terence S, Aravindan, Natarajan

    Published in PloS one (16-04-2013)
    “…Pancreatic cancer (PC) remains the fourth leading cause of cancer death with an unacceptable survival that has remained relatively unchanged over the past 25…”
    Get full text
    Journal Article
  3. 3

    Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression by Aravindan, Sheeja, Natarajan, Mohan, Awasthi, Vibhudutta, Herman, Terence S, Aravindan, Natarajan

    Published in PloS one (14-08-2013)
    “…Recently, we demonstrated that radiation (IR) instigates the occurrence of a NFκB-TNFα feedback cycle which sustains persistent NFκB activation in…”
    Get full text
    Journal Article
  4. 4

    Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes by Khan, Faizan H, Pandian, Vijayabaskar, Ramraj, Satishkumar, Natarajan, Mohan, Aravindan, Sheeja, Herman, Terence S, Aravindan, Natarajan

    Published in BMC cancer (10-07-2015)
    “…Determining the driving factors and molecular flow-through that define the switch from favorable to aggressive high-risk disease is critical to the betterment…”
    Get full text
    Journal Article
  5. 5

    Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols by Aravindan, Sheeja, Somasundaram, Dinesh Babu, Somasundaram, Somasundaram T., Natarajan, Mohan, Herman, Terence S., Aravindan, Natarajan

    Published in Molecular and cellular biochemistry (01-10-2019)
    “…The upsurge of marine-derived therapeutics for cancer treatment is evident, with many drugs in clinical use and in clinical trials. Seaweeds harbor large…”
    Get full text
    Journal Article
  6. 6

    Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells by Veeraraghavan, Jamunarani, Natarajan, Mohan, Lagisetty, Pallavi, Awasthi, Vibhudutta, Herman, Terence S, Aravindan, Natarajan

    Published in Pancreas (01-10-2011)
    “…Nuclear factor κB (NF-κB) plays an intrinsic role in promoting growth, angiogenesis, and metastasis in pancreatic cancer (PC) and serves as a mechanism…”
    Get full text
    Journal Article
  7. 7

    Cancer stem cells in neuroblastoma therapy resistance by Aravindan, Natarajan, Jain, Drishti, Somasundaram, Dinesh Babu, Herman, Terence S, Aravindan, Sheeja

    Published in Cancer drug resistance (19-12-2019)
    “…Neuroblastoma (NB) is the most common cancer of infancy and accounts for nearly one tenth of pediatric cancer deaths. This mortality rate has been attributed…”
    Get full text
    Journal Article
  8. 8

    Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells by Khan, Faizan H, Pandian, Vijayabaskar, Ramraj, Satishkumar, Aravindan, Sheeja, Herman, Terence S, Aravindan, Natarajan

    Published in BMC genomics (07-07-2015)
    “…MetastamiRs have momentous clinical relevance and have been correlated with disease progression in many tumors. In this study, we identified neuroblastoma…”
    Get full text
    Journal Article
  9. 9

    Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease by Ramraj, Satish Kumar, Aravindan, Sheeja, Somasundaram, Dinesh Babu, Herman, Terence S, Natarajan, Mohan, Aravindan, Natarajan

    Published in Oncotarget (05-04-2016)
    “…Circulating miRNAs have momentous clinical relevance as prognostic biomarkers and in the progression of solid tumors. Recognizing novel candidates of…”
    Get full text
    Journal Article
  10. 10

    Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples by Somasundaram, Dinesh Babu, Aravindan, Sheeja, Yu, Zhongxin, Jayaraman, Muralidharan, Tran, Ngoc T B, Li, Shibo, Herman, Terence S, Aravindan, Natarajan

    Published in BMC cancer (28-01-2019)
    “…MYCN amplification directly correlates with the clinical course of neuroblastoma and poor patient survival, and serves as the most critical negative prognostic…”
    Get full text
    Journal Article
  11. 11

    MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution by Aravindan, Natarajan, Subramanian, Karthikeyan, Somasundaram, Dinesh Babu, Herman, Terence S, Aravindan, Sheeja

    Published in Cancer drug resistance (01-01-2019)
    “…Neuroblastoma (NB) deriving from neural crest cells is the most common extra-cranial solid cancer at infancy. NB originates within the peripheral sympathetic…”
    Get full text
    Journal Article
  12. 12

    Abstract 2401: RD3-loss orchestrates GC-signaling independent evolution of progressive neuroblastoma by Meghna, Singh, Rachel, Wolansky, Herman, Terence S., Aravindan, Natarajan

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Recently we recognized the transcriptional/translational loss of Retinal degeneration Protein 3 (RD3) in high-risk progressive neuroblastoma (HR-NB)…”
    Get full text
    Journal Article
  13. 13
  14. 14

    De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution by Somasundaram, Dinesh Babu, Subramanian, Karthikeyan, Aravindan, Sheeja, Yu, Zhongxin, Natarajan, Mohan, Herman, Terence, Aravindan, Natarajan

    Published in Scientific reports (13-08-2019)
    “…Most high-risk neuroblastomas that initially respond to therapy will ultimately relapse. Currently, no curative treatment is available. Acquired…”
    Get full text
    Journal Article
  15. 15

    Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling by Aravindan, Sheeja, Natarajan, Mohan, Herman, Terence S, Awasthi, Vibhudutta, Aravindan, Natarajan

    Published in Radiation oncology (London, England) (04-03-2013)
    “…Heterogeneously distributed hypoxic areas are a characteristic property of locally advanced breast cancers (BCa) and generally associated with therapeutic…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy by Griffith, James, Andrade, Daniel, Mehta, Meghna, Berry, William, Benbrook, Doris M, Aravindan, Natarajan, Herman, Terence S, Ramesh, Rajagopal, Munshi, Anupama

    Published in Oncology reports (01-04-2017)
    “…Overexpression of BMI1 in human cancer cells, a member of the polycomb group of repressive complexes, correlates with advanced stage of disease, aggressive…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The Efficacy of Radiation Therapy in the Treatment of Graves’ Orbitopathy by Matthiesen, Chance, M.D, Thompson, J. Spencer, M.D, Thompson, David, Ph.D, Farris, Bradley, M.D, Wilkes, Byron, M.D, Ahmad, Salahuddin, Ph.D, Herman, Terence, M.D, Bogardus, Carl, M.D

    “…Purpose To review our institutional outcomes of patients treated with radiation therapy (RT) for Graves’ orbitopathy (GO), assess the role of orbital…”
    Get full text
    Journal Article
  20. 20

    Melatonin as a radioprotective agent: a review by Vijayalaxmi, Reiter, Russel J, Tan, Dun-Xian, Herman, Terence S, Thomas, Jr, Charles R

    “…Melatonin (N-acetyl-5-methoxytryptamine), the chief secretory product of the pineal gland in the brain, is well known for its functional versatility. In…”
    Get more information
    Journal Article